Astrazzinica begins to withdraw the Corona vaccine on the impact of "compensation cases"

While the judiciary in Britain is considering compensation claims against it, Astrazinica said on Tuesday that it began to withdraw its anti-coffee-19 vaccine from all over the world, because the “excessive vaccines are available”, as the outbreak of the pandemic and the company said it would begin with the withdrawal of the vaccination of the marketing licenses. She added: “With the development of multiple and variable vaccines for Kovid-19 since then, there has been a surplus in the updated vaccines available,” note that it has led to a decrease in the demand for Philatfastia, which “no longer makes or provides.” The British Swedish drug giant, earlier in British court documents, acknowledged that the vaccine causes side effects such as blood clots and a decrease in the number of platelets, according to the newspaper “Telegraph”, which was the first to publish these developments. The recognition comes within a collective lawsuit that says that the vaccine, developed at the University of Oxford; This caused the death and injury of dozens of cases, which could pave the way for the company to pay legal compensation in millions of pounds. Symptoms of the Astrazzinica vaccine, and Astrazinica, asked on the fifth of March to withdraw the vaccine and came into effect on Tuesday. According to “Telegraph” is Jimmy Scott, a father of two children, who sustained a chronic brain injury after sustaining a blood clot and bleeding after sustaining the Astrazinica vaccine in April 2021, which then prevented him from getting a chronic brain injury. In a legal document submitted to the Supreme Court in February, the company accepted that its anti -Corona virus may cause “in very rare cases, which is blood clotting with platelet syndrome, leading to people with blood clots and low platelets.” Britain’s Supreme Court is considering 51 cases against Astrazenica, as prosecutors and their family members are trying to obtain compensation estimated at about 100 million pounds. The rare nervous disorder and the Astrazzinica vaccine were the subject of repeated warnings years ago, and in September 2021, the periodic security updates issued by the European pharmaceutical agency showed that the agency added a rare neurological disorder, known as the ‘Gian Barr’, as a potential -Corona -Virus, to the slips, that the resentment, the action of the vaccine, allowed the sticks, that the contemporary conditions are, that it is equipped, that it is that the substances, the driven way, recipients. The agency said that a causal relationship between the syndrome and the vaccine was “at least a reasonable possibility” after reporting 833 cases of rare nerve disorder from 592 million doses of the vaccine given around the world until July 31, 2021. The European agency has described the side effect as “very rare”, which is the lowest level of the side effects, which emphasizes that its benefits are the increase. In June 2021, a senior European pharmaceutical agency official considered that it would be better to stop vaccination at the Astrazinica -anti vaccine for all age groups when other vaccines were available, while South Africa suspended the use of the Johnson & Johnson vaccine due to the pollution of the astrazina doses. “It is preferable to use the Johnson & Johnson vaccine for those older than sixty.” When asked if it was better to stop using Astrazzinica, also for people older than sixty years old, Cavalieri replied: “Yes, a choice that many countries, such as France and Germany, think of the increase in the availability of the RNA.” The Astrazzinica vaccine says ‘Mayo Clinic’ that the Astrazinica vaccine works with the ‘viral conveyor’ system, and whereby scientists take a substance of the ‘coffee-19’ virus and call it in a modified version of another virus, called the viral carrier, which in turn gives instructions to the body cells of the ‘SG protein’ To make corona virus. Once the cells’ proteins are exposed to their surfaces, the immune system responds by forming antibodies and defensive white blood cells. If the Corona virus is done later, the antibodies will be fought. Other vaccines work with the Mercy Ribzi acid system, which gives cells instructions on how to produce ‘st’ on the surface of the ‘Covey-19’ virus. After the vaccine is received, muscle cells begin to produce protein pieces and spread them to the surfaces of the cells, which stimulate the body to form antibodies. Astrazinica, listed in London, began to transform other vaccines last year, and obesity medicine by various transactions, after the growth was delayed with a decrease in ‘Cofide-19’ treatments.